Ventyx Biosciences, Inc.
VTYX
$2.77
$0.124.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.79M | 30.63M | 31.45M | 32.18M | 32.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.40M | 136.78M | 148.45M | 166.38M | 185.78M |
| Operating Income | -130.40M | -136.78M | -148.45M | -166.38M | -185.78M |
| Income Before Tax | -119.03M | -123.99M | -135.12M | -152.52M | -171.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -119.03 | -123.99 | -135.12 | -152.52 | -171.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -119.03M | -123.99M | -135.12M | -152.52M | -171.30M |
| EBIT | -130.40M | -136.78M | -148.45M | -166.38M | -185.78M |
| EBITDA | -130.11M | -136.48M | -148.18M | -166.12M | -185.55M |
| EPS Basic | -1.68 | -1.75 | -1.99 | -2.37 | -2.79 |
| Normalized Basic EPS | -1.05 | -1.10 | -1.24 | -1.48 | -1.74 |
| EPS Diluted | -1.68 | -1.75 | -1.99 | -2.37 | -2.79 |
| Normalized Diluted EPS | -1.05 | -1.10 | -1.24 | -1.48 | -1.74 |
| Average Basic Shares Outstanding | 283.81M | 283.16M | 273.86M | 262.13M | 250.34M |
| Average Diluted Shares Outstanding | 283.81M | 283.16M | 273.86M | 262.13M | 250.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |